Alcon Inc. Investors: Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.
Alcon Inc. Investors: Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. 1 The drop, formerly prescribed as Pazeo, joins Alcon's over-the-counter ocular allergy portfolio to meet a variety of patient needs The expansion of the Pataday portfolio of products will strengthen Alcon's leadership position in the U.S. eye allergy OTC market Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Pataday Once Daily Relief Extra Strength ( olopatadine hydrochloride ophthalmic solution 0.7%) is...
Source: finanznachrichten.de